Advertisement

POZ October/November 2019

POZ October/November 2019

In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.

Also Available On:

ISSUU

Features

Voces Latinas clients and staff—from left, back row: Nathaly Rubio-Torio and Sasha Franco; middle: Elia Rivera, Veronica Dominguez, Marisol Ramirez and Gloria Maldonado; front: Alexander Rodriguez and Ariel Diaz

Yearning to Breathe Free

Understanding Immigration and HIV

POZ Contributors

25 Years of Contributors

POZ writers and artists have thrived at the magical intersection of lived experience and boundless talent.

Editor’s Letter

Oriol R. Gutierrez

What’s Going On

Our cover story explores how HIV intersects with immigration and affects everyone from asylum seekers to longtime immigrants.

POZ Q+A

Christ Like book Emanuel Xavier

Poetic Justice

Lambda Literary speaks with Emanuel Xavier about the club scene, HIV/AIDS and the reissue of his cult novel.

POZ Planet

Prevention Power!

Updates on U=U, PrEP, harm reduction and more

POZ AT 25 — October/November

A look at fall issues from the POZ archives

Everyday

Everyday — October/November 2019

Here are some important dates in AIDS history.

Voices

HIV AIDS written on blackboard

Missing the Mark

Christine Soyong Harley, CEO of the U.S. Sexuality Information and Education Council, urges schools to address HIV.

man on couch texing on smart phone

Nice AF

Tony Taylor, a project manager at Building Healthy Online Communities, urges kindness.

Spotlight

HIV Border Crisis

Advocates respond to the reports that a father, who is living with HIV, was permanently separated from his daughters after entering the U.S.

Care And Treatment

bright sunrise

Very Early HIV Treatment Benefits

A new analysis of the global START trial found that health outcomes were better for those starting treatment within six months.

older grey haired man on couch with a coffe much reading the paper

Fostemsavir Can Best Drug-Resistant HIV

The attachment inhibitor plus an optimized antiretroviral background regimen suppressed HIV in the majority of study participants.

researchers working in the lab

Islatravir Shows Double Potential

Merck’s experimental HIV drug proves effective and well tolerated

Pharmacy sign with sky and palm trees behind

Pharmacists Can Oversee Hep C Treatment

Pharmacist-driven hep C treatment sees good cure rates

Research Notes

syringe laying on a map of Mexico showing Mexico City

Prevention: Vaccine Trial

The Mosaico study will enroll gay and bisexual men and transgender people at significant risk for the virus.

woman researcher in lab

Treatment: Capsid Inhibitor

The investigational, injectable, long-acting antiretroviral is a potential new option for those with multidrug resistance.

mouse and beakers against blue background

Cure: Mouse Gene Edit

CRISPR gene editing eliminates HIV in mice

man with blurred out face covering with his hands dramatic

Concerns: High Anxiety

A high proportion of people with HIV suffer from anxiety, which is associated with lower rates of HIV treatment and adherence to treatment.

Heroes

Oscar Lopez

Moving Mountains

Oscar Lopez advocates for Latinos living with HIV.

Digital Edition

POZ October/November 2019 cover

POZ October/November 2019

Read the digital edition!

Advertisement

Hot topics